01263nam a22003617a 450000500170000000800410001702200230005804000200008104100080010110000120010924501980012165000220031965000200034165000220036165000120038365000140039565000150040965000320042465000310045665000270048765000260051465000130054065000110055365000170056465000140058165000200059565100140061565300150062965500150064470000110065977300670067085601640073720210615153910.0200325b2019    sp ||||| |||| 00| 0 spa d  a0955-3959 (online)  aSIISbspadsiis  aeng  aDay, E.  aPriorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs  aDrogodependencias  aDrogas ilegales  aVía intravenosa  aConsumo  aHepatitis  aOpiáceos  aIntercambio de jeringuillas  aProgramas de mantenimiento  aReducción de daños  aReducción de riesgo  aBarreras  aAcceso  aPrevención  aReuniones  aRecomendaciones  aAustralia  aAdicciones  aDocumental  aet al.  gvol. 66, 2019, p. 87-93.tInternational Journal of Drug Policy  u\\Srvdatos\siis\docus\Revistas electrónicas\International Journal of Drug Policy R.1114\2019\Priorities and recommended actions for how researchers.pdfzPath